Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 07-Dec-21 4:30 PM View:  | Synta Pharmaceuticals Corp. (MDGL) | 03-Dec-21 | Disposition (other) | 800,000 | -- | -- | (34%) 2.34M to 1.54M | |
| 07-Dec-21 4:30 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 03-Dec-21 | Disposition (other) | 24,172 | -- | -- | (2%) 1.54M to 1.51M | |
| 26-Oct-21 5:02 PM View: | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Conversion | 816,990 | -- | -- | 100% 0 to 816.99K | |
| 26-Oct-21 5:02 PM View: | Xilio Therapeutics, Inc. (XLO) | 26-Oct-21 | Market Purchase | 312,500 | $16.00 | $5,000,000.00 | 38% 816.99K to 1.13M | |
| 01-Dec-20 9:36 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 01-Dec-20 | Disposition (other) | 43,537 | -- | -- | (2%) 2.35M to 2.31M | |
| 04-Sep-20 9:09 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 04-Sep-20 | Disposition (other) | 1,500,000 | -- | -- | (38%) 3.9M to 2.4M | |
| 04-Sep-20 9:09 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 04-Sep-20 | Disposition (other) | 45,460 | -- | -- | (2%) 2.4M to 2.35M | |
| 19-Aug-20 7:40 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 19-Aug-20 | Market Sale | 7,303 | $107.64 | $786,095.00 | (< 1%) 3.86M to 3.85M | |
| 19-Aug-20 7:40 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 18-Aug-20 | Market Sale | 10,197 | $110.03 | $1,121,980.00 | (< 1%) 3.87M to 3.86M | |
| 19-Aug-20 7:40 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 17-Aug-20 | Market Sale | 12,500 | $110.73 | $1,384,120.00 | (< 1%) 3.88M to 3.87M | |
| 29-May-20 4:51 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 27-May-20 | Disposition (other) | 367,333 | -- | -- | (9%) 4.3M to 3.93M | |
| 29-May-20 4:51 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 27-May-20 | Disposition (other) | 44,903 | -- | -- | (1%) 3.93M to 3.88M | |
| 16-Mar-20 5:08 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Mar-20 | Conversion | 703,380 | -- | -- | 102% 690.23K to 1.39M | |
| 13-Dec-19 2:18 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 13-Dec-19 | Market Sale Duplicate | 1,200,000 | $105.47 | $126,564,000.00 | (22%) 5.38M to 4.18M | 2% |
| 28-Jun-18 6:22 PM View: | Kezar Life Sciences, Inc. (KZR) | 25-Jun-18 | Conversion | 472,229 | -- | -- | 100% 0 to 472.23K | |
| 28-Jun-18 6:22 PM View: | Kezar Life Sciences, Inc. (KZR) | 25-Jun-18 | Purchase | 150,000 | $15.00 | $2,250,000.00 | 32% 472.23K to 622.23K | |
| 12-Jun-18 8:50 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 11-Jun-18 | Market Sale | 280,000 | $287.46 | $80,488,800.00 | (5%) 5.66M to 5.38M | 53% |
| 02-Aug-16 6:07 AM View: | Interleukin Genetics Inc. (ILIUE.PK) | 29-Jul-16 | Private Purchase | 30,181,100 | $0.10 | $3,000,000.00 | 64% 47.06M to 77.25M | |
| 12-Jan-16 4:30 PM View: | Epizyme, Inc. (EPZM) | 12-Jan-16 | Private Purchase Duplicate | 555,555 | $9.00 | $5,000,000.00 | 9% 6.2M to 6.75M | |
| 28-Jul-15 6:32 PM View: | Sunesis Pharmaceuticals Inc. (VIRX) | 24-Jul-15 | Private Sale | 635,702 | $3.46 | $2,199,530.00 | (5%) 11.86M to 11.23M | |
| 28-Jul-15 6:32 PM View: | Sunesis Pharmaceuticals Inc. (VIRX) | 24-Jul-15 | Exercise (in-the money or at-the-money) Duplicate | 1,665,830 | $1.32 | $2,198,900.00 | 16% 10.2M to 11.86M | |
| 17-Jun-15 9:02 PM View: | Nevro Corp (NVRO) | 08-Jun-15 | Market Sale | 491,835 | $47.94 | $23,578,600.00 | (22%) 2.22M to 1.73M | (281%) |
| 24-Dec-14 1:58 PM View: | Interleukin Genetics Inc. (ILIUE.PK) | 23-Dec-14 | Private Purchase | 26,492,000 | $0.10 | $2,657,140.00 | 129% 20.57M to 47.06M | |
| 12-Nov-14 11:09 AM View: | Nevro Corp (NVRO) | 12-Nov-14 | Conversion | 2,193,260 | -- | -- | 9155% 23.95K to 2.22M | |
| 08-Oct-14 4:17 PM View: | Dermira, Inc. (DERM) | 08-Oct-14 | Conversion | 3,420,300 | -- | -- | 19839% 17.24K to 3.44M | |
| 08-Oct-14 4:17 PM View: | Dermira, Inc. (DERM) | 08-Oct-14 | Purchase Duplicate | 69,112 | $16.00 | $1,105,790.00 | 2% 3.44M to 3.51M | |
| 29-Aug-14 4:05 PM View: | Sunesis Pharmaceuticals Inc. (VIRX) | 28-Aug-14 | Market Sale | 200,000 | $7.89 | $1,577,020.00 | (1%) 18.98M to 18.78M | 92% |
| 29-Aug-14 4:05 PM View: | Sunesis Pharmaceuticals Inc. (VIRX) | 27-Aug-14 | Market Sale | 100,700 | $8.16 | $822,014.00 | (< 1%) 19.08M to 18.98M | 93% |
| 28-Aug-14 6:09 PM View: | Epizyme, Inc. (EPZM) | 26-Aug-14 | Market Sale | 200,000 | $35.14 | $7,027,800.00 | (3%) 5.85M to 5.65M | 69% |
| 25-Aug-14 6:28 PM View: | Epizyme, Inc. (EPZM) | 25-Aug-14 | Market Sale | 200,000 | $35.14 | $7,027,800.00 | (3%) 5.85M to 5.65M | 69% |
| 25-Aug-14 6:28 PM View: | Epizyme, Inc. (EPZM) | 22-Aug-14 | Market Sale | 128,000 | $32.46 | $4,154,760.00 | (2%) 6.18M to 6.05M | 66% |
| 25-Aug-14 6:28 PM View: | Epizyme, Inc. (EPZM) | 21-Aug-14 | Market Sale | 38,666 | $33.04 | $1,277,340.00 | (< 1%) 6.35M to 6.31M | 67% |
| 12-Aug-14 5:54 PM View: | Sunesis Pharmaceuticals Inc. (VIRX) | 12-Aug-14 | Market Sale | 37,100 | $6.77 | $251,230.00 | (< 1%) 29.63M to 29.59M | 91% |
| 12-Aug-14 5:54 PM View: | Sunesis Pharmaceuticals Inc. (VIRX) | 11-Aug-14 | Market Sale | 31,600 | $6.90 | $218,103.00 | (< 1%) 29.66M to 29.63M | 91% |
| 12-Aug-14 5:54 PM View: | Sunesis Pharmaceuticals Inc. (VIRX) | 08-Aug-14 | Market Sale | 675,000 | $6.62 | $4,468,570.00 | (2%) 30.34M to 29.66M | 91% |
| 12-Feb-14 2:59 PM View: | Epizyme, Inc. (EPZM) | 10-Feb-14 | Market Sale | 466,667 | $29.25 | $13,650,000.00 | (7%) 6.86M to 6.39M | 64% |
| 21-Oct-13 6:19 PM View: | Hyperion Therapeutics Inc (HPTX) | 18-Oct-13 | Exercise (in-the money or at-the-money) | 200,000 | $26.00 | $5,200,000.00 | (9%) 2.12M to 1.92M | 4% |
| 19-Jul-13 7:57 PM View: | Hyperion Therapeutics Inc (HPTX) | 19-Jul-13 | Exercise (in-the money or at-the-money) | 5,200 | $26.69 | $138,788.00 | (< 1%) 2.12M to 2.12M | 7% |
| 19-Jul-13 7:57 PM View: | Hyperion Therapeutics Inc (HPTX) | 18-Jul-13 | Exercise (in-the money or at-the-money) | 3,703 | $26.00 | $96,278.00 | (< 1%) 2.12M to 2.12M | 4% |
| 19-Jul-13 7:57 PM View: | Hyperion Therapeutics Inc (HPTX) | 17-Jul-13 | Exercise (in-the money or at-the-money) | 87,000 | $26.00 | $2,262,000.00 | (4%) 2.21M to 2.12M | 4% |
| 11-Jul-13 6:08 PM View: | Hyperion Therapeutics Inc (HPTX) | 10-Jul-13 | Exercise (in-the money or at-the-money) | 51,830 | $22.35 | $1,158,300.00 | (1%) 4.53M to 4.48M | (12%) |
| 11-Jul-13 6:08 PM View: | Hyperion Therapeutics Inc (HPTX) | 09-Jul-13 | Exercise (in-the money or at-the-money) | 1,100 | $22.50 | $24,754.00 | (< 1%) 4.53M to 4.53M | (11%) |
| 08-Jul-13 7:04 PM View: | Hyperion Therapeutics Inc (HPTX) | 08-Jul-13 | Exercise (in-the money or at-the-money) | 8,900 | $22.50 | $200,250.00 | (< 1%) 4.55M to 4.54M | (11%) |
| 08-Jul-13 7:04 PM View: | Hyperion Therapeutics Inc (HPTX) | 05-Jul-13 | Exercise (in-the money or at-the-money) | 100 | $22.50 | $2,250.00 | (< 1%) 4.55M to 4.55M | (11%) |
| 08-Jul-13 7:04 PM View: | Hyperion Therapeutics Inc (HPTX) | 03-Jul-13 | Exercise (in-the money or at-the-money) | 13,300 | $22.50 | $299,315.00 | (< 1%) 4.57M to 4.55M | (11%) |
| 01-Jul-13 7:04 PM View: | Hyperion Therapeutics Inc (HPTX) | 28-Jun-13 | Exercise (in-the money or at-the-money) | 15,860 | $22.51 | $357,059.00 | (< 1%) 4.61M to 4.59M | (11%) |
| 01-Jul-13 7:04 PM View: | Hyperion Therapeutics Inc (HPTX) | 27-Jun-13 | Exercise (in-the money or at-the-money) | 10,000 | $22.53 | $225,333.00 | (< 1%) 4.62M to 4.61M | (11%) |
| 07-Jun-13 12:50 PM View: | Epizyme, Inc. (EPZM) | 05-Jun-13 | Conversion | 3,492,060 | -- | -- | 96% 3.66M to 7.15M | |
| 07-Jun-13 12:50 PM View: | Epizyme, Inc. (EPZM) | 05-Jun-13 | Purchase | 166,666 | $15.00 | $2,499,990.00 | 2% 7.15M to 7.31M | |
| 30-May-13 7:35 PM View: | Hyperion Therapeutics Inc (HPTX) | 30-May-13 | Market Sale | 5,366 | $21.00 | $112,686.00 | (< 1%) 4.62M to 4.61M | (19%) |